Inventor · disambiguated record
Daisuke Shii
Also filed as: SHII DAISUKE
4 granted patents·6 pending applications·12 citations·filing 2004–2023
71Inventor score
Top patents by PatentIndex Score
10 records- 0189US10435379B2[4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 8, 2019·5 cites·9 claims
- 0289US10189796B2[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 29, 2019·6 cites·26 claims
- 0383US11612590B2Therapeutic agent for meibomian dysfunctionSANTEN PHARMACEUTICAL CO LTD·Filed 2019·Granted Mar 28, 2023·1 cites·3 claims
- 0481US11951098B2Therapeutic agent for meibomian dysfunctionSANTEN PHARMACEUTICAL CO LTD·Filed 2023·Granted Apr 9, 2024·0 cites·12 claims
- 0563US2019359577A1[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1h-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 0658US2016022648A1Therapeutic agent for meibomian gland dysfunctionSANTEN PHARMACEUTICAL CO LTD·Filed 2014·Application pending·0 cites
- 0756US2018021314A1Therapeutic agent for meibomian dysfunctionSANTEN PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 0843US2006258703A1Remedy for pruritus comprising piperidine derivative as the active ingredientONO PHARMACEUTICAL CO·Filed 2004·Application pending·0 cites
- 0937US2008119498A1Therapeutic Agent for Pruritus Comprising P38 Map Kinase Inhibitor as the Active IngredientKATO MASATOMO·Filed 2005·Application pending·0 cites
- 1034US2014121901A1Electrical power supply control system, electrical power supply control device, and electrical power supply control methodSHII DAISUKE·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daisuke Shii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →